As global health consumption upgrades and demand for natural products continues to rise, plant extracts, as the core carrier connecting traditional herbal wisdom with modern applications, are entering a critical period of industrial transformation and upgrading. As a core category of traditional Chinese medicine (TCM) exports, plant extracts have long accounted for more than 50% of China's total TCM export volume. Among them, cnidium monnieri extract has stood out in the niche market due to its unique pharmacological value and diverse application scenarios. The 10:1 specification product, in particular, has become a core growth driver in the foreign trade market by balancing efficacy, cost-effectiveness and adaptability, driving the industry to move steadily towards standardization and high-valueization.
Industry Background: Plant Extracts Enter a Period of Quality Improvement and Transformation, with Cnidium Monnieri Extract Showing Great Potential
As the world's largest producer and exporter of plant extracts, China has formed a complete industrial chain layout after more than half a century of development, with an increasingly improved system covering raw material planting, extraction and processing, and export trade. According to industry data, China's total import and export volume of plant extracts reached 3.69 billion US dollars in 2025, of which the export volume was 2.98 billion US dollars, accounting for 58.6% of China's total TCM export volume. Although there was a slight fluctuation affected by the global economic environment, the overall development remained stable. The industry is transforming from a single rough processing in the past to comprehensive utilization of full components and high value, with quality improvement and differentiated competition becoming the core development goals.
As a traditional TCM, cnidium monnieri has a medicinal history of thousands of years. The Pharmacopoeia clearly states that it has the effects of drying dampness and dispelling wind, killing insects and relieving itching, and warming the kidney and tonifying yang, which can be used for the conditioning and treatment of pruritus vulvae and leukorrhea, eczema and pruritus, kidney deficiency and impotence, and other conditions. With the in-depth development of modern pharmacological research, osthole, the core active component of cnidium monnieri, has been further explored. Its anti-inflammatory, antibacterial, antioxidant and other properties have been widely used in medicine, cosmetics, health products, agriculture and other fields, laying a solid foundation for the market expansion of cnidium monnieri extract. At the same time, the Group Standard T/CAPDA 015-2021 "Cnidium Monnieri Extract Soluble Concentrate" issued by the China Association of Pesticide Development and Application has clearly standardized the technical requirements, test methods and quality control of cnidium monnieri extract, promoting the industry's transformation from disorderly competition to standardized development and providing compliance guarantee for the export of 10:1 cnidium monnieri extract.
Product Core: Why Has 10:1 Cnidium Monnieri Extract Become the Main Choice in the Foreign Trade Market?
Among the various specifications of cnidium monnieri extract, the 10:1 extraction ratio has become the first choice of overseas purchasers due to its core advantages of "balanced efficacy, wide adaptability and outstanding cost-effectiveness", especially favored by core export markets such as the United States, Japan and India. The so-called 10:1 extraction ratio means that 10 parts of cnidium monnieri raw materials are used to directionally obtain and concentrate active components such as osthole through standardized extraction, concentration, separation, drying and other processes, and finally 1 part of extract is obtained. This ratio not only avoids the disadvantages of insufficient active components and unobvious efficacy of low-ratio extracts, but also overcomes the problems of high cost and limited application scenarios of high-ratio extracts, achieving the optimal balance between efficacy and cost.
In terms of production technology, high-quality 10:1 cnidium monnieri extract adopts new technologies such as ultrasonic-assisted extraction and membrane separation. Compared with the traditional solvent extraction method, it has the advantages of high extraction efficiency, no solvent residue and complete retention of active components, which can effectively ensure the stable content of osthole. According to the requirements of the Group Standard T/CAPDA 015-2021, the osthole content of cnidium monnieri extract must meet clear technical indicators, and must be accurately detected by high-performance liquid chromatography (wavelength 322nm) to ensure controllable product quality. Taking China's mainstream manufacturers as an example, they have now realized self-controlled planting of cnidium monnieri raw materials, controlling raw material quality from the source to eliminate pesticide residues and heavy metal exceeding standards. At the same time, they have set up a professional technical team, which has been engaged in the production and research of osthole for many years, and can realize large-scale and standardized production of 10:1 specification products to meet the batch demand and quality requirements of foreign trade orders.
In terms of application scenarios, 10:1 cnidium monnieri extract has extremely strong adaptability, covering multi-field needs: in the medical field, it can be used as a pharmaceutical intermediate for the research and development of preparations for treating skin pruritus, rheumatic arthralgia, reproductive system diseases and other diseases; in the cosmetics field, due to its mild and non-irritating characteristics, it can be added to moisturizing, antipruritic and anti-inflammatory skin care products, conforming to the trend of green transformation in the global cosmetics industry; in the health product field, it can be used as a natural health component for the development of dietary supplements that regulate immunity and improve reproductive health; in the agricultural field, it can be made into soluble concentrate for the prevention and control of crop diseases and insect pests, in line with the concept of green agricultural development.
Foreign Trade Market: Diversified Demand Upgrade, Export Potential of 10:1 Cnidium Monnieri Extract Continues to Release
At present, China's plant extract exports show a pattern of "stable key markets with changes and rapid rise of emerging markets". The top five export markets, the United States, Japan, India, Spain and South Korea, account for nearly 50% of the total export volume. With its standardized quality and diverse applications, 10:1 cnidium monnieri extract has performed brilliantly in these markets.
As China's largest export market for plant extracts, the United States had an export volume of 590 million US dollars in 2025. Although it decreased slightly year-on-year, the demand for natural plant extracts remains strong. 10:1 cnidium monnieri extract is widely used in the research and development of health products because it meets the raw material standards of the US dietary supplement industry; as the second largest export market, Japan's export volume increased by 18.1% year-on-year in 2025. The demand for cnidium monnieri extract in its Kampo medicine industry continues to rise. The 10:1 specification has become the core category for export to Japan due to its stable component concentration and adaptability to the preparation requirements of Kampo medicine; as an export market with continuous growth for 3 years, India's export volume reached 280 million US dollars in 2025. The rapid development of its medical and cosmetics industries has provided a broad market space for 10:1 cnidium monnieri extract.
From the perspective of industry data, the global market size of cnidium monnieri extract is growing steadily, and it is expected to achieve significant breakthroughs by 2030. As a core supplier, China occupies an important share of the global market by virtue of its advantages in raw materials, technology and cost. At present, the main suppliers of cnidium monnieri extract in the international market are concentrated in China. Among them, enterprises with large-scale production capacity and strict quality control system are gradually expanding their market share with mainstream products such as 10:1, competing with international manufacturers such as Herbo Nutra and Naturalin.
Industry Challenges and Development Prospects: Guided by Standardization, Breaking Through with High-Valueization
Although the cnidium monnieri extract market has great potential, the industry still faces many challenges: first, the instability of raw material supply. The lack of standardized specifications for cnidium monnieri planting in some areas leads to uneven raw material quality; second, the serious internal competition in the industry. Some enterprises ignore product quality by means of low-price competition, affecting the international reputation of China's cnidium monnieri extract; third, insufficient technological innovation. Some enterprises still adopt traditional extraction technology, resulting in low product added value, which is difficult to meet the needs of the high-end market.
Looking forward to the future, with the continuous improvement of industry standards and the continuous innovation of technology, the cnidium monnieri extract industry will enter a period of high-quality development. On the one hand, standardization will become the core main line of industry development. Enterprises will strictly follow relevant standards such as T/CAPDA 015-2021, realize full-process quality control from raw material planting, production and processing to inspection and acceptance, and improve the international recognition of products; on the other hand, technological innovation will promote the high-value upgrading of products. Enterprises will increase investment in the research and development of new extraction technologies and separation and purification technologies, optimize the process of mainstream products such as 10:1, and develop high-end products such as high-purity osthole extract to expand the high-end foreign trade market.
In addition, green and sustainable development will become the industry consensus. Enterprises will gradually promote the ecological planting mode of cnidium monnieri, reduce the use of pesticides and chemical fertilizers, and realize the sustainable supply of raw materials; at the same time, optimize the production process, reduce energy consumption and environmental pollution, and promote the industry to develop in a green and low-carbon direction. For foreign trade enterprises, it is necessary to accurately grasp the needs of overseas markets, focus on core products such as 10:1 cnidium monnieri extract, strengthen brand building and channel expansion, improve the international competitiveness of products, and seize the development opportunities of the global natural product market.
As an important category in the plant extract niche market, the development of cnidium monnieri extract not only carries the mission of modernization of traditional TCM, but also conforms to the trend of global natural health consumption. As the main choice in the foreign trade market, 10:1 cnidium monnieri extract, with its balanced efficacy, wide adaptability and standardized quality, is leading the industry to transform towards quality improvement, efficiency enhancement and high-valueization. It is expected to occupy a more important position in the global plant extract market in the future and inject new momentum into China's plant extract exports.
